Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00540306 · ClinicalTrials.gov registry record
Monitoring Functional Variation in the Breast During Menstrual Cycle by Using Diffuse Optical Spectroscopy
A clinical trial of Accessory; Breast Tissue, sponsored by University of California, Irvine.
- Completed
- Registry status
- 13
- Enrollment target
- 1
- Study location
NCT00540306: Completed study of Accessory; Breast Tissue, sponsored by University of California, Irvine.
NCT00540306 is a study of Accessory; Breast Tissue that has completed, run by University of California, Irvine. The registered enrollment target is 13 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00540306, a study of Accessory; Breast Tissue, has completed, sponsored by University of California, Irvine.
- COMPLETED
- Registry status
- 13 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to do determine the changes in physiological and optical properties in healthy pre-menopausal breast tissue during the menstrual cycle using Diffuse Optical Spectroscopy. The Researcher can determine 1) how large variations in breast tissue components are 2) how predictable and repeatable these variations are 3) the effects of endogenous hormones on breast tissue physiology.
Primary Outcome
Changes in physiological and optical properties in healthy pre-menopausal breast tissue during the menstrual cycle
Conditions Studied
Interventions
- DEVICE Diffuse Optical Spectroscopy
Study Locations (1)
California
- Beckman Laser Institute University of California Irvine - Irvine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2006-02 |
| Est. Completion | 2012-10 |
What the finished NCT00540306 record still lists
NCT00540306 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 13 participants, a relatively small participant target.
The record links to 1 condition, with Accessory; Breast Tissue appearing as the primary indexed condition, and to 1 intervention - of which Diffuse Optical Spectroscopy is the first listed.
NCT00540306 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT00540306 about?
NCT00540306 is a clinical study titled "Monitoring Functional Variation in the Breast During Menstrual Cycle by Using Diffuse Optical Spectroscopy". The purpose of this study is to do determine the changes in physiological and optical properties in healthy pre-menopausal breast tissue during the menstrual cycle using Diffuse Optical Spectroscopy. The Researcher can determine 1) how large variations in breast tissue components are 2) how predicta...
What is the current status of trial NCT00540306?
This trial is currently completed. The enrollment target is 13 participants. The study started on 2006-02. Estimated completion is 2012-10.
What conditions does trial NCT00540306 study?
This clinical trial studies the following conditions: Accessory; Breast Tissue.
What interventions are being tested in trial NCT00540306?
The interventions under investigation include: Diffuse Optical Spectroscopy (DEVICE).
Who is sponsoring clinical trial NCT00540306?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00540306 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia